Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/ce/b4/9e/ceb49ee3-edfb-d218-63cd-746101f39733/mza_2804619413719298064.jpg/600x600bb.jpg
PeerVoice Immunology & Infectious Disease Video
PeerVoice
74 episodes
2 months ago
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
RSS
All content for PeerVoice Immunology & Infectious Disease Video is the property of PeerVoice and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Show more...
Science
Education,
How To,
Health & Fitness,
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/ce/b4/9e/ceb49ee3-edfb-d218-63cd-746101f39733/mza_2804619413719298064.jpg/600x600bb.jpg
Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
PeerVoice Immunology & Infectious Disease Video
19 minutes 34 seconds
1 year ago
Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
Visit https://www.peervoice.com/BBT860 to view the entire programme with slides. After completing “Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?”, participants will be able to: Describe the benefits and limitations of current disease-modifying strategies in multiple sclerosis (MS); Discuss the role of Bruton’s tyrosine kinase (BTK) in the pathological processes associated with disease progression in patients with MS; and Use clinical data to evaluate on-target and off-target effects of emerging BTK inhibitors for patients with MS in the context of current clinical management.
PeerVoice Immunology & Infectious Disease Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.